Mechanistic Target of Rapamycin (mTOR) in the Cancer Setting

Area of Science:

• Cell Biology
• Oncology
• Molecular Biology

Background:

• The mammalian target of rapamycin (mTOR) pathway plays a critical role in regulating cell growth and is implicated in various cancers.
• Cancer cells often hijack mTOR signaling to promote their uncontrolled proliferation and survival.

Discussion:

• This special issue examines the multifaceted roles of mTOR in cancer, extending beyond its well-established function in protein synthesis.
• It highlights how cancer cells leverage mTOR for processes including autophagy, cell cycle progression, metabolic reprogramming, and angiogenic signaling.
• Further discussions encompass mTOR's involvement in nucleotide and ribosomal biogenesis, cell migration, inflammation, and the regulation of transcription factors crucial for tumor progression.

Key Insights:

• mTOR is a central regulator of anabolic processes essential for cancer cell growth, such as nucleotide and ribosomal biogenesis.
• Dysregulation of mTOR signaling contributes to metabolic transformation and supports the survival and proliferation of cancer cells.
• mTOR influences multiple hallmarks of cancer, including sustained proliferative signaling, evasion of growth suppressors, and angiogenesis.

Outlook:

• Targeting the mTOR pathway presents a promising therapeutic strategy for various cancers.
• Further research into the complex network of mTOR signaling could reveal novel therapeutic targets and combination strategies.
• Understanding the diverse roles of mTOR in cancer progression is vital for developing more effective anti-cancer treatments.